MOBILEYE GLOBAL INC-A (MBLY)

US60741F1049 - Common Stock

17.51  -0.21 (-1.19%)

After market: 17.5999 +0.09 (+0.51%)

Fundamental Rating

4

Overall MBLY gets a fundamental rating of 4 out of 10. We evaluated MBLY against 82 industry peers in the Automobile Components industry. MBLY has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, MBLY is valued expensive at the moment.



3

1. Profitability

1.1 Basic Checks

In the past year MBLY was profitable.
MBLY had a positive operating cash flow in the past year.
MBLY had negative earnings in each of the past 5 years.
In the past 5 years MBLY always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of MBLY (-23.45%) is worse than 91.46% of its industry peers.
Looking at the Return On Equity, with a value of -24.47%, MBLY is doing worse than 84.15% of the companies in the same industry.
Industry RankSector Rank
ROA -23.45%
ROE -24.47%
ROIC N/A
ROA(3y)-0.38%
ROA(5y)N/A
ROE(3y)-0.4%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of MBLY (46.86%) is better than 98.78% of its industry peers.
In the last couple of years the Gross Margin of MBLY has grown nicely.
MBLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MBLY has been increased compared to 1 year ago.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 16.30 indicates that MBLY is not in any danger for bankruptcy at the moment.
MBLY has a better Altman-Z score (16.30) than 98.78% of its industry peers.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.3
ROIC/WACCN/A
WACC9.57%

2.3 Liquidity

MBLY has a Current Ratio of 5.80. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
MBLY has a Current ratio of 5.80. This is amongst the best in the industry. MBLY outperforms 95.12% of its industry peers.
MBLY has a Quick Ratio of 4.54. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.54, MBLY belongs to the top of the industry, outperforming 95.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.8
Quick Ratio 4.54

5

3. Growth

3.1 Past

MBLY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.00%.
MBLY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.26%.
The Revenue has been growing by 29.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
Revenue 1Y (TTM)-10.26%
Revenue growth 3Y29.07%
Revenue growth 5YN/A
Sales Q2Q%-8.3%

3.2 Future

Based on estimates for the next years, MBLY will show a very strong growth in Earnings Per Share. The EPS will grow by 21.12% on average per year.
The Revenue is expected to grow by 17.97% on average over the next years. This is quite good.
EPS Next Y-71.07%
EPS Next 2Y-28.92%
EPS Next 3Y-9.42%
EPS Next 5Y21.12%
Revenue Next Year-21.16%
Revenue Next 2Y-3.04%
Revenue Next 3Y5.21%
Revenue Next 5Y17.97%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 43.77, which means the current valuation is very expensive for MBLY.
Compared to the rest of the industry, the Price/Earnings ratio of MBLY indicates a slightly more expensive valuation: MBLY is more expensive than 74.39% of the companies listed in the same industry.
MBLY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.73.
Based on the Price/Forward Earnings ratio of 42.79, the valuation of MBLY can be described as expensive.
MBLY's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. MBLY is more expensive than 76.83% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, MBLY is valued quite expensively.
Industry RankSector Rank
PE 43.78
Fwd PE 42.79

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MBLY is valued expensively inside the industry as 86.59% of the companies are valued cheaper.
MBLY's Price/Free Cash Flow ratio is rather expensive when compared to the industry. MBLY is more expensive than 80.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF 66.36
EV/EBITDA 96.88

4.3 Compensation for Growth

MBLY's earnings are expected to decrease with -9.42% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-28.92%
EPS Next 3Y-9.42%

0

5. Dividend

5.1 Amount

MBLY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (12/20/2024, 8:23:36 PM)

After market: 17.5999 +0.09 (+0.51%)

17.51

-0.21 (-1.19%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)01-23 2025-01-23/amc
Inst Owners12.13%
Inst Owner Change-14.67%
Ins Owners0.75%
Ins Owner Change27.38%
Market Cap14.20B
Analysts71.52
Price Target19.92 (13.76%)
Short Float %21.75%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.22%
Min EPS beat(2)0.46%
Max EPS beat(2)17.98%
EPS beat(4)3
Avg EPS beat(4)2.88%
Min EPS beat(4)-8.52%
Max EPS beat(4)17.98%
EPS beat(8)7
Avg EPS beat(8)17.34%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.46%
Min Revenue beat(2)1.32%
Max Revenue beat(2)1.6%
Revenue beat(4)3
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-2.39%
Max Revenue beat(4)1.6%
Revenue beat(8)4
Avg Revenue beat(8)0.13%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.8%
PT rev (3m)-21.21%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)-47.22%
EPS NY rev (1m)-0.47%
EPS NY rev (3m)2.63%
Revenue NQ rev (1m)-0.61%
Revenue NQ rev (3m)-27.88%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE 43.78
Fwd PE 42.79
P/S 7.89
P/FCF 66.36
P/OCF 46.56
P/B 1.18
P/tB 6.58
EV/EBITDA 96.88
EPS(TTM)0.4
EY2.28%
EPS(NY)0.41
Fwd EY2.34%
FCF(TTM)0.26
FCFY1.51%
OCF(TTM)0.38
OCFY2.15%
SpS2.22
BVpS14.89
TBVpS2.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.45%
ROE -24.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.86%
FCFM 11.88%
ROA(3y)-0.38%
ROA(5y)N/A
ROE(3y)-0.4%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9%
GM growth 5YN/A
F-Score5
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 17.98%
Cap/Sales 5.05%
Interest Coverage N/A
Cash Conversion 225.93%
Profit Quality N/A
Current Ratio 5.8
Quick Ratio 4.54
Altman-Z 16.3
F-Score5
WACC9.57%
ROIC/WACCN/A
Cap/Depr(3y)21.96%
Cap/Depr(5y)19.71%
Cap/Sales(3y)6.99%
Cap/Sales(5y)7.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
EPS Next Y-71.07%
EPS Next 2Y-28.92%
EPS Next 3Y-9.42%
EPS Next 5Y21.12%
Revenue 1Y (TTM)-10.26%
Revenue growth 3Y29.07%
Revenue growth 5YN/A
Sales Q2Q%-8.3%
Revenue Next Year-21.16%
Revenue Next 2Y-3.04%
Revenue Next 3Y5.21%
Revenue Next 5Y17.97%
EBIT growth 1Y-352.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-65.9%
EBIT Next 3Y-1.22%
EBIT Next 5Y17.07%
FCF growth 1Y-31.95%
FCF growth 3Y18.03%
FCF growth 5YN/A
OCF growth 1Y-27.84%
OCF growth 3Y13.29%
OCF growth 5YN/A